Scilex Holding (SCLX) Shareholder's Equity Growth (1y) (2021 - 2026)

Scilex Holding (SCLX) Shareholder's Equity Growth (1y) (2021 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -20.14%
Dec 31, 2025 -7.86%
Sep 30, 2025 16.27%
Jun 30, 2025 -15.97%
Mar 31, 2025 -11.43%
Dec 31, 2024 -11.39%
Sep 30, 2024 -29.91%
Jun 30, 2024 -2,160.98%
Mar 31, 2024 -1,813.49%
Dec 31, 2023 -577.22%
Sep 30, 2023 29.09%
Jun 30, 2023 104.13%
Mar 31, 2023 104.78%
Dec 31, 2022 116.19%
Sep 30, 2022 -2,233.67%
Jun 30, 2022 -2,906.36%
Mar 31, 2022 -2,740.74%
Dec 31, 2021 -58.01%
Sep 30, 2021 -51,446.56%
Jun 30, 2021 -167,608.66%